Dietary modification and supplementation for the treatment of age-related macular degeneration

Nutrition Reviews

Volumn 73, Issue 7, 2015, Pages 448-462

  Broadhead, Geoffrey K ^a,b   Grigg, John R ^a   Chang, Andrew A ^a,b   McCluskey, Peter ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Sydney Institute of Health Sciences   (Australia)

Author keywords

Age related macular degeneration; Antioxidants; Diet; Dietary supplements

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CARBOHYDRATE; CAROTENOID; CHOLESTEROL; COPPER; FAT; GLUCOSE; OMEGA 3 FATTY ACID; RETINOL; VISUAL PIGMENT; VITAMIN; VITAMIN D; XANTHOPHYLL; ZEAXANTHIN; ZINC; CARBOHYDRATE DIET; FAT INTAKE; GLUCOSE BLOOD LEVEL; TRACE ELEMENT;

AGE RELATED MACULAR DEGENERATION; ARTICLE; CARBOHYDRATE DIET; CARBOHYDRATE INTAKE; CHOLESTEROL INTAKE; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DIET SUPPLEMENTATION; DIET THERAPY; FAT INTAKE; FISH; GENOTYPE; GEOGRAPHIC ATROPHY; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; LEAFY VEGETABLE; NONHUMAN; NUT; NUTRIENT; OPTICAL DENSITY; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ADMINISTRATION AND DOSAGE; ANIMAL; CALORIC INTAKE; DISEASE COURSE; FEEDING BEHAVIOR; GENETICS; HEALTH CARE POLICY; MACULAR DEGENERATION; METABOLISM; SEA FOOD; VEGETABLE;

ANIMALS; BLOOD GLUCOSE; CAROTENOIDS; CHOLESTEROL; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; ENERGY INTAKE; FISHES; FOOD HABITS; HUMANS; MACULAR DEGENERATION; MICRONUTRIENTS; NUTRITION POLICY; NUTS; SEAFOOD; VEGETABLES; VITAMIN D;

EID: 84940197403     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/nutrit/nuv005     Document Type: Article

References (140)

1. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572.
2. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-1431.
3. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-1444.
4. Klein R, Chou CF, Klein BE, et al. Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol. 2011;129:75-80.
5. Erke MG, Bertelsen G, Peto T, et al. Prevalence of age-related macular degeneration in elderly Caucasians: the Tromso Eye Study. Ophthalmology. 2012; 119:1737-1743.
6. Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2012;11:CD000254. doi: 10.1002/14651858.CD000254.pub3.
7. Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev. 2012;6: CD000253. doi: 10.1002/14651858.CD000253.pub2.
8. van Lookeren Campagne M, LeCouter J, Yaspan BL, et al. Mechanisms of agerelated macular degeneration and therapeutic opportunities. J Pathol. 2014;232: 151-164.
9. Pennesi ME, Neuringer M, Courtney RJ. Animal models of age related macular degeneration. Mol Aspects Med. 2012;33:487-509.
10. Mettu PS, Wielgus AR, Ong SS, et al. Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration. Mol Aspects Med. 2012;33:376-398.
11. Kinnunen K, Petrovski G, Moe MC, et al. Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol. 2012;90:299-309.
12. Weikel KA, Chiu CJ, Taylor A. Nutritional modulation of age-related macular degeneration. Mol Aspects Med. 2012;33:318-375.
13. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421.
14. Shaw PX, Zhang L, Zhang M, et al. Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids. Proc Natl Acad Sci U S A. 2012;109:13757-13762.
15. Chakravarthy U, Wong TY, Fletcher A, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010;10:31. doi: 10.1186/1471-2415-10-31.
16. Age-Related Eye Diseases Study Research Group. A randomized, placebocontrolled, zclinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-436.
17. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega- 3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309:2005-2015.
18. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study report no. 6. Am J Ophthalmol. 2001;132:668-681.
19. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. Control Clin Trials. 1999; 20:573-600.
20. Danis RP, Domalpally A, Chew EY, et al. Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 report number 2). Invest Ophthalmol Vis Sci. 2013;64: 4548-4554.
21. Chiu CJ, Klein R., Milton RC, et al. Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-Related Eye Disease Study supplements? Br J Ophthalmol. 2009;93:1241-1246.
22. Chiu CJ, Milton RC, Gensler G, et al. Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age- Related Eye Disease Study. Am J Clin Nutr. 2007;86:180-188.
23. National Eye Institute: Facts about age-related macular degeneration. http://www.nei.nih.gov/health/maculardegen/armd_facts.asp. Updated July 2013. Accessed September 30, 2013.
24. Chowdhury R, Stevens S, Gorman D, et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ. 2012;345:e6698. doi: 10.1136/bmj.e6698.
25. SanGiovanni JP, Neuringer M. The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field. Am J Clin Nutr. 2012;96:1223S-1233S.
26. Schleicher M, Weikel K, Garber C, et al. Diminishing risk for age-related macular degeneration with nutrition: a current view. Nutrients. 2013;5:2405-2456.
27. Chiu CJ, Taylor A. Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Prog Retin Eye Res. 2011;30:18-53.
28. Zampatti S, Ricci F, Cusumano A, et al. Review of nutrient actions on age-related macular degeneration. Nutr Res. 2014;34:95-105.
29. Cho E, Hung S, Willett WC, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr. 2001;73:209-218.
30. Chua B, Flood V, Rochtchina E, et al. Dietary fatty acids and the 5-year incidence of age-related maculopathy. Arch Ophthalmol. 2006;124:981-986.
31. SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS report no. 20. Arch Ophthalmol. 2007;125:671-679.
32. Sangiovanni JP, Agron E, Meleth AD, et al. Ω-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. Am J Clin Nutr. 2009;90: 1601-1607.
33. Tan JS, Wang JJ, Flood V, et al. Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol. 2009;127:656-665.
34. Reynolds R, Rosner B, Seddon JM. Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy. Ophthalmology. 2013;120:1020-1028.
35. Chong EW, Kreis AJ, Wong TY, et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol. 2008;126:826-833.
36. Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol. 2003;121:1728-1737.
37. Souied EH, Delcourt C, Querques G, et al. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 Study. Ophthalmology. 2013;120:1619-1631.
38. Garcia-Layana A, Recalde S, Alaman AS, et al. Effects of lutein and docosahexaenoic acid supplementation on macular pigment optical density in a randomized controlled trial. Nutrients. 2013;5:543-551.
39. Dawczynski J, Jentsch S, Schweitzer D, et al. Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study. Graefes Arch Clin Exp Ophthalmol. 2013;251:2711-2723.
40. Cangemi FE. TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD. BMC Ophthalmol. 2007;7:3.
41. Lawrenson JG, Evans JR. Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2012;11:CD010015. doi:10.1186/1471-2415-7-3.
42. Gerstenblith AT, Baskin DE, Shah CP, et al. Electroretinographic effects of omega- 3 fatty acid supplementation on dry age-related macular degeneration. JAMA Ophthalmol. 2013;131:365-369.
43. Robman L, Vu H, Hodge A, et al. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Can J Ophthalmol. 2007;42:720-726.
44. Chong EW, Robman LD, Simpson JA, et al. Fat consumption and its association with age-related macular degeneration. Arch Ophthalmol. 2009;127:674-680.
45. Parekh N, Voland RP, Moeller SM, et al. Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women's Health Initiative. Arch Ophthalmol. 2009;127:1483-1493.
46. Seddon JM, Rosner B, Sperduto RD, et al. Dietary fat and risk for advanced agerelated macular degeneration. Arch Ophthalmol. 2001;119:1191-1199.
47. Smith W, Mitchell P, Leeder SR. Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol. 2000;118:401-404.
48. Chong EW, Simpson JA, Robman LD, et al. Red meat and chicken consumption and its association with age-related macular degeneration. Am J Epidemiol. 2009;169:867-876.
49. SanGiovanni JP, Chew EY, Agron E, et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol. 2008;126:1274-1279.
50. Mares JA, Voland RP, Sondel SA, et al. Healthy lifestyles related to subsequent prevalence of age-related macular degeneration. Arch Ophthalmol. 2011;129: 470-480.
51. Chiu CJ, Milton RC, Klein R, et al. Dietary compound score and risk of age-related macular degeneration in the Age-Related Eye Disease Study. Ophthalmology. 2009;116:939-946.
52. Klein R, Cruickshanks KJ, Nash SD, et al. The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol. 2010;128:750-758.
53. Jenkins DJ, Wolever TM, Taylor RH, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981;34:362-366.
54. Salmeron J, Manson JE, Stampfer MJ, et al. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA. 1997;277:472-477.
55. Kristo AS, Matthan NR, Lichtenstein AH. Effect of diets differing in glycemic index and glycemic load on cardiovascular risk factors: review of randomized controlled- feeding trials. Nutrients. 2013;5:1071-1080.
56. Kaushik S, Wang JJ, Flood V, et al. Dietary glycemic index and the risk of agerelated macular degeneration. Am J Clin Nutr. 2008;88:1104-1110.
57. Chiu CJ, Milton RC, Klein R, et al. Dietary carbohydrate and the progression of age-related macular degeneration: a prospective study from the Age-Related Eye Disease Study. Am J Clin Nutr. 2007;86:1210-1218.
58. Chiu CJ, Hubbard LD, Armstrong J, et al. Dietary glycemic index and carbohydrate in relation to early age-related macular degeneration. Am J Clin Nutr. 2006;83:880-886.
59. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994;272:1413-1420.
60. Cho E, Seddon JM, Rosner B, et al. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol. 2004;122:883-892.
61. Flood V, Smith W, Wang JJ, et al. Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology. 2002;109:2272-2278.
62. Tan JS, Wang JJ, Flood V, et al. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 2008;115:334-341.
63. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA. 2005;294:3101-3107.
64. Eye Disease Case-Control Study Group. Antioxidant status and neovascular agerelated macular degeneration. Arch Ophthalmol. 1993;111:104-109.
65. SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report no. 22. Arch Ophthalmol. 2007;125:1225-1232.
66. Mares-Perlman JA, Klein R, Klein BE, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol. 1996;114:991-997.
67. Vishwanathan R, Chung M, Johnson EJ. A systematic review on zinc for the prevention and treatment of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013;54:3985-3998.
68. Rochtchina E, Wang JJ, Flood VM, et al. Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the Blue Mountains Eye Study. Am J Ophthalmol. 2007;143:344-346.
69. Kamburoglu G, Gumus K, Kadayifcilar S, et al. Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2006;244:565-569.
70. Taylor HR, Tikellis G, Robman LD, et al. Vitamin E supplementation and macular degeneration: randomised controlled trial. BMJ. 2002;325:11. doi: http://dx.doi. org/10.1136/bmj.325.7354.11.
71. Teikari JM, Laatikainen L, Virtamo J, et al. Six-year supplementation with alphatocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol Scand. 1998;76:224-229.
72. Christen WG, Glynn RJ, Chew EY, et al. Vitamin E and age-related macular degeneration in a randomized trial of women. Ophthalmology. 2010;117: 1163-1168.
73. Christen WG, Glynn RJ, Sesso HD, et al. Vitamins E and C and medical recordconfirmed age-related macular degeneration in a randomized trial of male physicians. Ophthalmology. 2012;119:1642-1649.
74. Christen WG, Glynn RJ, Manson JE, et al. A Multivitamin supplement and cataract and age-related macular degeneration in a randomized trial of male physicians. Ophthalmology. 2014;121:525-534.
75. Newsome DA, Swartz M, Leone NC, et al. Oral zinc in macular degeneration. Arch Ophthalmol. 1988;106:192-198.
76. Newsome DA. A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration. Curr Eye Res. 2008;33:591-598.
77. Stur M, Tittl M, Reitner A, et al. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1225-1235.
78. Montgomery MP, Kamel F, Pericak-Vance MA, et al. Overall diet quality and agerelated macular degeneration. Ophthalmic Epidemiol. 2010;17:58-65.
79. Chew EY, Clemons TE, Agron E, et al. Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. Ophthalmology. 2013;120:1604-1611.
80. Charkoudian LD, Gower EW, Solomon SD, et al. Vitamin usage patterns in the prevention of advanced age-related macular degeneration. Ophthalmology. 2008;115:1032-1038.e4.
81. Hochstetler BS, Scott IU, Kunselman AR, et al. Adherence to recommendations of the Age-Related Eye Disease Study in patients with age-related macular degeneration. Retina. 2010;30:1166-1170.
82. Sasaki M, Shinoda H, Koto T, et al. Use of micronutrient supplement for preventing advanced age-related macular degeneration in Japan. Arch Ophthalmol. 2012;130:254-255.
83. Shah SU, Pilli S, Telander DG, et al. Survey of patients with age-related macular degeneration: knowledge and adherence to recommendations. Can J Ophthalmol. 2013;48:204-209.
84. Lawrenson JG, Evans JR. Advice about diet and smoking for people with or at risk of age-related macular degeneration: a cross-sectional survey of eye care professionals in the UK. BMC Public Health. 2013;13:564. doi: 10.1186/1471-2458-13-564.
85. Ma L, Dou HL, Wu YQ, et al. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. Br J Nutr. 2012;107:350-359.
86. Chew EY, Clemons TE, Sangiovanni JP, et al. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report no. 3. JAMA Ophthalmol. 2014;132:142-149.
87. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330:1029-1035.
88. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005; 293:1338-1347.
89. Clemons TE, Kurinij N, Sperduto RD. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age- Related Eye Disease Study: AREDS report no. 13. Arch Ophthalmol. 2004;122: 716-726.
90. Cho E, Hankinson SE, Rosner B, et al. Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration. Am J Clin Nutr. 2008;87: 1837-1843.
91. Piermarocchi S, Saviano S, Parisi V, et al. Carotenoids in Age-Related Maculopathy Italian Study (CARMIS): two-year results of a randomized study. Eur J Ophthalmol. 2012;22:216-225.
92. Beatty S, Chakravarthy U, Nolan JM, et al. Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology. 2013;120:600-606.
93. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004;75: 216-230.
94. Murray IJ, Makridaki M, van der Veen RL, et al. Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study. Invest Ophthalmol Vis Sci. 2013;54:1781-1788.
95. Bucheli P, Vidal K, Shen L, et al. Goji berry effects on macular characteristics and plasma antioxidant levels. Optom Vis Sci. 2011;88:257-262.
96. Parisi V, Tedeschi M, Gallinaro G, et al. Carotenoids and Antioxidants in Age- Related Maculopathy Italian Study: multifocal electroretinogram modifications after 1 year. Ophthalmology. 2008;115:324-333.e2.
97. Ma L, Dou HL, Huang YM, et al. Improvement of retinal function in early agerelated macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial. Am J Ophthalmol. 2012; 154:625-634.e1.
98. Sasamoto Y, Gomi F, Sawa M, et al. Effect of 1-year lutein supplementation on macular pigment optical density and visual function. Graefes Arch Clin Exp Ophthalmol. 2011;249:1847-1854.
99. Ma L, Yan SF, Huang YM, et al. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophthalmology. 2012;119:2290-2297.
100. Richer SP, Stiles W, Graham-Hoffman K, et al. Randomized, double-blind, placebo- controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. Optometry. 2011;82:667-680.e6.
101. Loughman J, Nolan JM, Howard AN, et al. The impact of macular pigment augmentation on visual performance using different carotenoid formulations. Invest Ophthalmol Vis Sci. 2012;53:7871-7880.
102. Falsini B, Piccardi M, Iarossi G, et al. Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electrophysiologic assessment. Ophthalmology. 2003;110:51-60; discussion 61.
103. Burke JD, Curran-Celentano J, Wenzel AJ. Diet and serum carotenoid concentrations affect macular pigment optical density in adults 45 years and older. J Nutr. 2005;135:1208-1214.
104. Raman R, Biswas S, Vaitheeswaran K, et al. Macular pigment optical density in wet age-related macular degeneration among Indians. Eye. 2012;26: 1052-1057.
105. Raman R, Biswas S, Gupta A, et al. Association of macular pigment optical density with risk factors for wet age-related macular degeneration in the Indian population. Eye. 2012;26:950-957.
106. Mares JA, LaRowe TL, Snodderly DM, et al. Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative. Am J Clin Nutr. 2006;84:1107-1122.
107. Nolan JM, Loughman J, Akkali MC, et al. The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS. Vision Res. 2011;51:459-469.
108. Connolly EE, Beatty S, Loughman J, et al. Supplementation with all three macular carotenoids: response, stability, and safety. Invest Ophthalmol Vis Sci. 2011;52: 9207-9217.
109. Curran-Celentano J, Hammond BR Jr, Ciulla TA, et al. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr. 2001;74: 796-802.
110. Moeller SM, Voland R, Sarto GE, et al. Women's Health Initiative diet intervention did not increase macular pigment optical density in an ancillary study of a subsample of the Women's Health Initiative. J Nutr. 2009;139:1692-1699.
111. Puell MC, Palomo-Alvarez C, Barrio AR, et al. Relationship between macular pigment and visual acuity in eyes with early age-related macular degeneration. Acta Ophthalmol. 2013;91:e298-e303.
112. Loughman J, Akkali MC, Beatty S, et al. The relationship between macular pigment and visual performance. Vision Res. 2010;50:1249-1256.
113. Stringham JM, Hammond BR Jr. The glare hypothesis of macular pigment function. Optom Vis Sci. 2007;84:859-864.
114. Stringham JM, Hammond BR. Macular pigment and visual performance under glare conditions. Optom Vis Sci. 2008;85:82-88.
115. Hammond BR Jr, Wooten BR. CFF thresholds: relation to macular pigment optical density. Ophthalmic Physiol Opt. 2005;25:315-319.
116. Patryas L, Parry NR, Carden D, et al. The association between dark adaptation and macular pigment optical density in healthy subjects. Graefes Arch Clin Exp Ophthalmol. 2014;252:657-663.
117. Yao Y, Qiu QH, Wu XW, et al. Lutein supplementation improves visual performance in Chinese drivers: 1-year randomized, double-blind, placebo-controlled study. Nutrition. 2013;29:958-964.
118. Rodriguez-Carmona M, Kvansakul J, Harlow JA, et al. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision. Ophthalmic Physiol Opt. 2006;26:137-147.
119. Kvansakul J, Rodriguez-Carmona M, Edgar DF, et al. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance. Ophthalmic Physiol Opt. 2006;26:362-371.
120. Engles M, Wooten B, Hammond B. Macular pigment: a test of the acuity hypothesis. Invest Ophthalmol Vis Sci. 2007;48:2922-2931.
121. Weigert G, Kaya S, Pemp B, et al. Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:8174-8178.
122. Richer S, Devenport J, Lang JC. LAST II: differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls. Optometry. 2007;78: 213-219.
123. Bernstein PS, Ahmed F, Liu A, et al. Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center. Invest Ophthalmol Vis Sci. 2012;53:6178-6186.
124. Kaya S, Weigert G, Pemp B, et al. Comparison of macular pigment in patients with age-related macular degeneration and healthy control subjects - a study using spectral fundus reflectance. Acta Ophthalmol. 2012;90: e399-e403.
125. LaRowe TL, Mares JA, Snodderly DM, et al. Macular pigment density and agerelated maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the Women's Health Initiative. Ophthalmology. 2008;115: 876-883.e1.
126. Kanis MJ, Berendschot TT, van Norren D. Influence of macular pigment and melanin on incident early AMD in a white population. Graefes Arch Clin Exp Ophthalmol. 2007;245:767-773.
127. Dietzel M, Zeimer M, Heimes B, et al. Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the Muenster Aging and Retina Study (MARS). Invest Ophthalmol Vis Sci. 2011;52: 3452-3457.
128. Gopinath B, Flood VM, Rochtchina E, et al. Homocysteine, folate, vitamin B-12, and 10-y incidence of age-related macular degeneration. Am J Clin Nutr. 2013; 98:129-135.
129. Christen WG, Glynn RJ, Chew EY, et al. Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med. 2009;169:335-341.
130. Millen AE, Voland R, Sondel SA, et al. Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol. 2011;129: 481-489.
131. Falsini B, Piccardi M, Minnella A, et al. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51:6118-6124.
132. Piccardi M, Marangoni D, Minnella AM, et al. A longitudinal follow-up study of saffron supplementation in early age-related macular degeneration: sustained benefits to central retinal function. Evid Based Complement Alternat Med. 2012; 2012:429124. doi: 10.1155/2012/429124.
133. Arnold C, Jentsch S, Dawczynski J, et al. Age-related macular degeneration: effects of a short-term intervention with an oleaginous kale extract-a pilot study. Nutrition. 2013;29:1412-1417.
134. Edwards AO, Ritter R III, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421-424.
135. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005;14:3227-3236.
136. Ho L, van Leeuwen R, Witteman JC, et al. Reducing the genetic risk of agerelated macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam Study. Arch Ophthalmol. 2011;129:758-766.
137. Wang JJ, Buitendijk GH, Rochtchina E, et al. Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations. Ophthalmology. 2014;121:667-675.
138. Broadhead GK, Chang A, McCluskey P. Genetics in age-related macular degeneration: current research and implications for future treatment. Asia Pac J Ophthalmol. 2012;1:312-318.
139. Klein ML, Francis PJ, Rosner B, et al. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology. 2008;115:1019-1025.
140. Awh CC, Lane AM, Hawken S, et al. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. Ophthalmology. 2013;120:2317-2323.